Meningococcal Vaccine Resources

Meningococcal disease is uncommon but moves fast — it can turn a seemingly healthy teenager critically ill within hours, and roughly 10 to 15 percent of people who get it die even with prompt antibiotic treatment. Among survivors, many live with permanent consequences such as limb loss, hearing loss, or brain injury. Because adolescents and young adults carry elevated risk, vaccination remains the most reliable protection available to Louisiana families. The resource packet below collects parent-facing explanations of what meningococcal disease is, how it spreads, when preteens and teens should be vaccinated, what side effects to expect, and how the Vaccines for Children program helps families who are uninsured or Medicaid-eligible. The materials were produced by the U.S. Centers for Disease Control and Prevention and by Immunize.org (formerly the Immunization Action Coalition), whose Q&A section was reviewed for technical content by the CDC; the Louisiana Chapter of the American Academy of Pediatrics distributes them here as a service to member practices and the families they serve. Please note that these handouts were last updated in 2015, and both the licensed vaccine products and the recommendation language have changed since then. Use them for foundational background, and confirm dosing, timing, and product selection against the current CDC/ACIP immunization schedule before counseling a family or administering a dose.

DownloAd the PDF